LATONYA MANN: Open Payments
NPI 1649675620 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 6 payments from 6 companies in 2025. Trend: 2023 $551 · 2024 $1,740 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 1 | $135 |
| Xeris Pharmaceuticals, Inc. | 1 | $135 |
| AstraZeneca Pharmaceuticals LP | 1 | $126 |
| GlaxoSmithKline, LLC. | 1 | $69 |
| Novo Nordisk Inc | 1 | $67 |
| Janssen Biotech, Inc. | 1 | $33 |
Products named: ZEPZELCA, GVOKE HYPOPEN, FASENRA, NUCALA, Ozempic, RYBREVANT.
Industry payments across DE — which companies pay providers there.
